Capsule
REVLIMID CAPSULES 15MG (SWITZERLAND)
Summary
REVLIMID CAPSULES 15MG (SWITZERLAND) — Capsule containing lenalidomide. Hong Kong Registration No. HK-62181. Certificate Holder: BRISTOL-MYERS SQUIBB PHARMA (HK) LTD. Date of Registration: 25 Sep, 2013.
Product NameREVLIMID CAPSULES 15MG (SWITZERLAND)
Registration No.HK-62181
Certificate HolderBRISTOL-MYERS SQUIBB PHARMA (HK) LTD
Holder AddressRM 3001-3002 30/F, WINDSOR HOUSE, 311, GLOUCESTER RD., CAUSEWAY BAY, HONG KONG
Ingredientslenalidomide
Dosage FormCapsule
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration25 Sep, 2013
ATC codesL04AX04
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL04
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。